CGON vs HOOD · rev $4.0M vs P/E 48, rev $2.38B
CG Oncology, Inc. Common stock (CGON) versus Robinhood Markets Inc (HOOD) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vlad Tenev.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
CGON currently screens at market cap $4.74B. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Not investment advice. Open the CGON and HOOD stock pages for the full models.
Not investment advice.